PMC:7600245 / 81828-82003 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T859","span":{"begin":40,"end":46},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T860","span":{"begin":165,"end":171},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"rombotic complications. Most frequently tested anti-inflammatory/immunomodulatory agents are listed in Table 2. Antithrombotic agents that are most frequently being tested in "}

{"project":"LitCovid-sentences","denotations":[{"id":"T641","span":{"begin":24,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"rombotic complications. Most frequently tested anti-inflammatory/immunomodulatory agents are listed in Table 2. Antithrombotic agents that are most frequently being tested in "}